Sequoia Financial Advisors LLC grew its holdings in Monsanto Company (NYSE:MON) by 8.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 31,627 shares of the basic materials company’s stock after buying an additional 2,381 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Monsanto were worth $3,743,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Puplava Financial Services Inc. lifted its holdings in Monsanto by 0.4% in the 2nd quarter. Puplava Financial Services Inc. now owns 2,119 shares of the basic materials company’s stock worth $251,000 after buying an additional 9 shares during the period. Savant Capital LLC lifted its holdings in Monsanto by 0.4% in the 1st quarter. Savant Capital LLC now owns 3,082 shares of the basic materials company’s stock worth $349,000 after buying an additional 11 shares during the period. Guardian Life Insurance Co. of America lifted its holdings in Monsanto by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock worth $191,000 after buying an additional 11 shares during the period. Enterprise Financial Services Corp lifted its holdings in Monsanto by 1.2% in the 2nd quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock worth $164,000 after buying an additional 16 shares during the period. Finally, Forward Management LLC lifted its holdings in Monsanto by 0.5% in the 2nd quarter. Forward Management LLC now owns 3,201 shares of the basic materials company’s stock worth $379,000 after buying an additional 16 shares during the period. Institutional investors and hedge funds own 74.79% of the company’s stock.

A number of research analysts have recently commented on the company. UBS AG cut Monsanto from a “positive” rating to a “neutral” rating in a research note on Tuesday, June 27th. Royal Bank Of Canada restated a “hold” rating and issued a $128.00 target price on shares of Monsanto in a research note on Wednesday, August 2nd. Piper Jaffray Companies set a $128.00 target price on Monsanto and gave the company a “buy” rating in a research note on Friday, August 11th. Jefferies Group LLC cut Monsanto from a “buy” rating to a “hold” rating and set a $128.00 target price for the company. in a research note on Wednesday, July 12th. Finally, Barclays PLC raised their target price on Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a research note on Thursday, June 29th. One research analyst has rated the stock with a sell rating, twelve have issued a hold rating and eight have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $123.43.

Shares of Monsanto Company (MON) opened at 117.23 on Tuesday. The firm has a 50 day moving average price of $117.21 and a 200-day moving average price of $116.35. The company has a market cap of $51.50 billion, a price-to-earnings ratio of 25.32 and a beta of 1.07. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $118.97.

Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. During the same quarter in the prior year, the business posted $2.17 EPS. The business’s revenue for the quarter was up 1.0% compared to the same quarter last year. On average, equities analysts expect that Monsanto Company will post $4.89 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be issued a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. Monsanto’s dividend payout ratio is presently 46.75%.

In other news, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Steven Mizell sold 11,300 shares of the stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the sale, the executive vice president now owns 55,011 shares of the company’s stock, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. Corporate insiders own 0.79% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/09/12/monsanto-company-mon-shares-bought-by-sequoia-financial-advisors-llc.html.

Monsanto Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.